688617.SH
惠泰医疗
SSE · Healthcare · Medical - Devices · CN
CNY 258.57
−1.87%Sep 3, 2026, 07:36 UTC
Huitai Medical appointed Zhao Yuxiang as executive deputy general manager, responsible for marketing, at its board meeting on September 3, 2026.
Source:Aug 28, 2026, 13:59 UTC
On August 28, 2026, a block trade of 670,400 shares of Huatai Medical (Shenzhen Huatai Medical Devices Co., Ltd.) was executed at 248.04 yuan per share, totaling 166 million yuan, with the buyer being an institutional desk and the seller being China International Capital Corporation Shanghai branch.
Source:Aug 19, 2026, 09:49 UTC
Huitai Medical launched a restricted stock incentive plan, initially granting 1.7805 million restricted shares to 663 incentive recipients at a grant price of 240 yuan per share.
Source:Aug 19, 2026, 09:49 UTC
Huitai Medical announced its 2026 first-half results with total revenue of 1.526 billion yuan, up 25.75% year-on-year, and net profit attributable to shareholders of 537 million yuan, up 26.38%.
Source: